Pathophysiological effects of radiation on atherosclerosis development and progression, and the incidence of cardiovascular complications

SR Basavaraju, CE Easterly - Medical physics, 2002 - Wiley Online Library
Radiation therapy while important in the management of several diseases, is implicated in
the causation of atherosclerosis and other cardiovascular complications. Cancer and …

What is IL-1 for? The functions of interleukin-1 across evolution

D Boraschi - Frontiers in immunology, 2022 - frontiersin.org
Interleukin-1 is a cytokine with potent inflammatory and immune-amplifying effects, mainly
produced by macrophages during defensive reactions. In mammals, IL-1 is a superfamily of …

The role of tumor necrosis factor and interleukin 1 in the immunoinflammatory response

JW Larrick, SL Kunkel - Pharmaceutical research, 1988 - Springer
Monocytes and tissue macrophages produce at least two groups of protein mediators of
inflammation, interleukin 1 (IL-1) and tumor necrosis factor (TNF). Recent studies have …

Tfr cells lack IL-2Rα but express decoy IL-1R2 and IL-1Ra and suppress the IL-1–dependent activation of Tfh cells

PGG Ritvo, G Churlaud, V Quiniou, L Florez… - Science …, 2017 - science.org
Follicular regulatory T (Tfr) cells from lymph node germinal centers control follicular helper T
(Tfh) cell–dependent B cell activation. These scarce cells, often described and purified as …

Interleukin‐1β, but not interleukin‐1α, is required for T‐cell‐dependent antibody production

S Nakae, M Asano, R Horai, Y Iwakura - Immunology, 2001 - Wiley Online Library
Summary Interleukin‐1 (IL‐1) consists of two molecules, IL‐1α and IL‐1β, and IL‐1 receptor
antagonist (IL‐1Ra) is a natural inhibitor of these molecules. Although the adjuvant effects of …

Interleukin 1 or tumor necrosis factor can promote Coxsackie B3-induced myocarditis in resistant B10. A mice.

JR Lane, DA Neumann, A Lafond-Walker… - Journal of Experimental …, 1992 - rupress.org
Materials and Methods Animals. The C57BL/10 (B10. A) mice were originally purchased
from The Jackson Laboratory (Bar Harbor, ME), and bred and maintained in our animal …

Crystallographic refinement of interleukin 1 beta at 2.0 A resolution.

JP Priestle, HP Schär, MG Grütter - … of the National Academy of Sciences, 1989 - pnas.org
The structure of human recombinant interleukin 1 beta (IL-1 beta) has been refined by a
restrained least-squares method to a crystallographic R factor of 17.2% to 2.0 A resolution …

IL-1 is an effective adjuvant for mucosal and systemic immune responses when coadministered with protein immunogens

HF Staats, FA Ennis - The Journal of Immunology, 1999 - journals.aai.org
Mucosal immunization with soluble protein Ag alone may induce Ag-specific tolerance,
whereas mucosal immunization with Ag in the presence of a mucosal adjuvant may induce …

Modulating dendritic cells to optimize mucosal immunization protocols

E Williamson, GM Westrich, JL Viney - The Journal of Immunology, 1999 - journals.aai.org
Oral administration of soluble protein Ag induces tolerance, a phenomenon that has
hampered mucosal vaccine design. To provoke active immunity, orally administered Ag …

Cytokines as immunological adjuvants

AW Heath, JHL Playfair - Vaccine, 1992 - Elsevier
Various cytokines have been shown to be effective immunological adjuvants in a variety of
model systems, enhancing protection induced by viral, bacterial and parasitic vaccines, and …